The sequence of retractions began at the end of 2022, when anonymous comments made on the PubPeer website alleged that the pharmacists articles contained duplicate images and repeated content
BPC-157 and TB-500 are 503A compounded peptides administered under licensed medical supervision at Perfect B
Recalls & Warnings June 26, 2024 FDA Warns Consumers Not to Use Infla-650 Due to Undeclared Drugs On June 20, 2024, the FDA warned consumers not to purchase or use Infla-650 after FDA laboratory analysis found them to contain acetaminophen, diclofenac, and phenylbutazone
Berberine improves vascular dysfunction by inhibiting trimethylamine-N-oxide via regulating the gut microbiota in angiotensin II-induced hypertensive mice
Per the discussion above, this also has implications in the treatment of vasculogenic ED [11, 23, 24]
Quinto L